AllianceBernstein’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Buy |
+30,600
| New | +$196K | ﹤0.01% | 3058 |
|
|
2024
Q2 | – | Sell |
-51,542
| Closed | -$146K | – | 3235 |
|
|
2024
Q1 | $146K | Hold |
51,542
| – | – | ﹤0.01% | 2984 |
|
|
2023
Q4 | $759K | Hold |
51,542
| – | – | ﹤0.01% | 2405 |
|
|
2023
Q3 | $944K | Hold |
51,542
| – | – | ﹤0.01% | 2273 |
|
|
2023
Q2 | $1.11M | Hold |
51,542
| – | – | ﹤0.01% | 2222 |
|
|
2023
Q1 | $1.51M | Buy |
51,542
+15,300
| +42% | +$449K | ﹤0.01% | 2019 |
|
|
2022
Q4 | $1.34M | Hold |
36,242
| – | – | ﹤0.01% | 2136 |
|
|
2022
Q3 | $1.02M | Buy |
36,242
+342
| +1% | +$9.63K | ﹤0.01% | 2274 |
|
|
2022
Q2 | $691K | Buy |
+35,900
| New | +$691K | ﹤0.01% | 2525 |
|